Member Info for LochinvarLass

*calculations not continuations (not sure how my fingers typed that - must be time for a cuppa)

Think we have all done the continuations about how long it would be before a rights issue was needed - if if it was just waving a crystal over a calendar - LOL.

Key personnel taking a 1/4 pay cut and signing on for options at 8.5p made it a sure bet that it was sooner rather than later. I'm sure they will spend that £15m wisely. I'm also hoping they gear up to do the commercial deals they will need to produce the profits down the line.

I would like to find out the requirement for "Qualifying Shareholder" - between my trade and ISA accounts, I'm hoping I might have a chance.

Miavoce, I hope you are right.

My personal view is that Scancell should be part of the heart/hub of the future vaccine CoE the UK is looking to capitalise upon in the future.

I'm very glad they didn't need to do it at a 4.5p to raise the £15M they needed. If the SP falls back, then it's an opportunity to pick up more. I can put all my research into buying rights from my ISA held shares into the next exercise.

I'm also heartened that Scancell are picking up institutional investors.

Details:

Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer, today announces a proposed conditional Capital Raise to raise in aggregate up to approximately £15 million before expenses, comprising:

· a Subscription for 90,909,090 New Ordinary Shares for £5 million at an Issue Price of 5.5 pence per share by funds managed by Redmile Group LLC, a US based specialist healthcare and life sciences investment firm;

· a subscription for Convertible Loan Notes with an aggregate principal amount of £6 million and conversion price of 6.2 pence per share (subject to customary adjustments), with £5 million in principal amount to be subscribed for by the Redmile Funds and £1 million in principal amount to be subscribed for by Vulpes;

· a Placing with new and existing institutional Shareholders to raise approximately £2 million at an Issue Price of 5.5 pence per New Ordinary Share, of which Vulpes intends to subscribe for 18,181,818 new Ordinary Shares for £1 million; and

· an open offer to Qualifying Shareholders of up to £2 million at the Issue Price of 5.5 pence per New Ordinary Share.

Indeed. Perhaps the 2nd is because Onwurah didn't think the first answer was satisfactory. I'm going to study both answers and make up my own mind before ticking a box at the bottom of each question. I encourage others to do the same.

I'm all for every vaccine which helps in the short term - there are Billions who may need inoculation. Scancell's is the only one which I've read about thus far which may provide some protection for the next covids.

And that is for both questions....

Snap - the question has been answered - see my post.

My question to the BB was whether the answer provided satisfied the question.

link https://www.theyworkforyou.com/wrans/?id=2020-07-13.72904.h

Apologies if this was posted on Monday - it didn't come up in my search until tonight.

Exchange:
Chi Onwurah Shadow Minister (Business, Energy and Industrial Strategy), Shadow Minister (Digital, Culture, Media and Sport)
To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the length of time it has taken Nottingham University's Scancell COVID-19 Vaccine group to receive Government funding in comparison to similar groups in (a) Oxford and (b) Imperial universities.

Answered by Amanda Solloway Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy):
No such assessment has been made on the length of time taken. The government understands the urgency of the response to COVID-19 and set up a rapid response R&D fund, to accelerate research proposals into the disease. All applications to the UKRI-DHSC rapid response call are assessed on their own merits and awards made so far can be found at:

https://mrc.ukri.org/funding/browse/ukri-nihr-covid-19/ukri-nihr-covid-19-rolling-call/?_ga=2.186583657.1164498350.1594986614-294529872.1594986614.

The funding calls and processes for Scancell, Oxford and Imperial have different requirements and are of different scales, therefore the timings required to make a proper and fair assessment should not be compared.
******

There is a tick box at the bottom of the page to say if you think the question was answered. Any thoughts by those here interested?

Regarding the holding back of the dividend. Johnson's Government specifically asked banks to hold back the dividend because the capital may be needed. Other industries did not have quite such a strong "suggestion".

I'm happy that the final divi from 2019 will be honoured and will seek to add more at the right price.

FYI, believe you are entirely correct that LLOY bailed out two institutions and have been recovering from the aftermath of that ever since. I've not met their current CEO, but I've watched a few meetings he's been in and I was impressed. I wish him all the best and believe he did well to eliminate the Government stake so quickly.

Thanks for these links - the first is the link to sun article I posted here a few days ago and have tweeted. It helps delineate Scancell's approach from the others, and its strategic value. I don't care which health journo publishes it - my view is that more is better!

This is very interesting news if true.

Ball said the Government should invest in a portfolio of Covid19 vaccines, and they have started that. I will keep asking the "daft lassie questions" and posting that Sky tweet until I'm sure they have enough to prove Phase 1 and Phase 2 - particularly because I believe their focus is more strategic and provides additional benefits for many above a certain age...

We have had a good couple of days, even given the large sell. Think someone say 7p by end July - I'm hoping that is the new normal baseline from tomorrow.

Goodnight all!

I struggle to keep up with the threads here, so I missed which s/he this refers to. Knowing you are not a racist is all you need to hold close.

As far as I'm concerned, none of get to pick the colour of the skin we are born with or when/where we land on planet A. I was lucky enough to have parents who pushed us to excel (even though it still feels like they were disappointed we were not "more").

Boutique gin distilling could become big business in Scotland (as in grow even more). Gin takes far longer to age, and because it can be infused with many different flavours, Gin tastings have been quite popular for a few years.

I was debating about growing some which have berries which have been popular for gin as well as cancer "homeopathy". Somewhere I've bookmarked or saved the article which lists the latter, and I can get the former off the sales figures.

Sun is out today! Something to be said about enjoying a walk by the loch. Midges are out in force though in the boggy areas.

I thought the divi news would be by the end of the month, thanks for letting us know the dates

(last year declaration on 30 July and xd on 8th August I think)

I am chuffed that Scancell retweeted the tweet I posted with your link. Thank you for posting it.

Indeed. I've been invited to join any number of special interest What's app groups and have held off, even for Covid19 issues.

Currently the P11D tax benefit on all electric cars is ZERO 0%, making the e-Jaguar worth the investment as the full charge cost is around £9 or so. . . Other all-electric cars are even cheaper.

The only issue is that the network of charge points needs to be expanded.

Personally, I'm hoping to afford that saltwater tech car that was proven over 5 years ago. I can pack a few bottles out of the lock and then zoom zoom up and down the hills.

I've posted my view on Brexit elsewhere - Parliament shuts down tomorrow until 1 September. The stock market appears to think that is a good thing (just joking).

As for the US elections, both Trump and Biden are near the age when my Dad died. I know a lot of Democrats boycotted the 2016 presidential election in 2016. Surely some won't make that mistake again.